The shares of Biocon Limited were down 9 per cent during the morning trade on Friday after the company posted 18 per cent lower profits at ₹169 crore for the third-quarter of FY 2020-21.
At 11:15 am, Biocon was trading at ₹401.75 on the BSE, down ₹40.20 or 9.10 per cent. It hit an intraday high of ₹424.00 and an intraday low of ₹399.45. Biocon opened at ₹424.00 as against previous close of ₹441.95.
On the NSE, it was trading at ₹401.70, down ₹40.25 or 9.11 per cent.
Biocon net profit down 18 per cent to ₹169 cr on Covid impact
Biocon Ltd on Thursday posted 18 per cent lower profits at ₹169 crore for the third-quarter of FY 2020-21 on a consolidated basis as against ₹206 crore posted last year despite good revenues from research services and biosimilars business.
However, the company’s revenue for Q3FY21 stood ₹ 1,879 crore, up 7 per cent as against ₹1,753 crore in the same period last year.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.